Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn's disease: An open-label, multicenter, prospective trial

Inflammatory Bowel Diseases

Volumn 19, Issue 2, 2013, Pages 293-300

  Reinisch, Walter ^a   Knobler, Robert ^a   Rutgeerts, Paul J ^b   Ochsenkühn, Thomas ^c   Anderson, Frank ^d   Von Tirpitz, Christian ^e   Kaatz, Martin ^f   Van Der Woude, C Janneke ^g   Parenti, Dennis ^h   Mannon, Peter J ⁱ  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF MUNICH   (Germany)

^d LAIR Centre   (Canada)

^e UNIVERSITY OF ULM   (Germany)

^f FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^g ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^h Therakos Johnson and Johnson   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Crohn's disease; Extracorporeal photopheresis; Steroid dependent

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CROHN; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EXTRACORPOREAL PHOTOPHERESIS; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUVA; QUESTIONNAIRE; RELAPSE; REMISSION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INDUCTION CHEMOTHERAPY; INTENTION TO TREAT ANALYSIS; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; PHOTOPHERESIS; PREDNISONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876419846     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.23012     Document Type: Article

References (16)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;12;369:1641-1657.
2. Yang YX, Lichtenstein GR. Corticosteroids in Crohn's disease. Am J Gastroenterol. 2002;97:803-823.
3. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260.
4. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 1994;35:360-362.
5. Reinisch W, Gasché C, Wyatt J, et al. Steroid dependency in Crohn's disease. Lancet. 1995;1:345:859.
6. Franchimont DP, Louis E, Croes F, et al. Clinical pattern of corticosteroid dependent Crohn's disease. Eur J Gastroenterol Hepatol. 1998;10:821-825.
7. Charpignon C, Beau P. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited? Gastroenterol Clin Biol. 2008;32:153-157.
8. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362: 1383-1395.
9. Savill J, Dransfield I, Gregory C, et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002;2: 965-975.
10. Stuart L, Hughes J. Apoptosis and autoimmunity. Nephrol Dial Transplant. 2002;17:697-700.
11. Aubin F, Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance? Transplantation. 2004;77(1 Suppl):S29-S31.
12. Maeda A, Schwarz A, Kernebeck K, et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol. 2005;174:5968-5976.
13. McKenna KE, Whittaker S, Rhodes LE, et al. Evidence-based practice of photopheresis; a report of a workshop of the British Photodermatology Group and the UK Skin Lymphoma Group. Br J Dermatol. 2006;154:7-20.
14. Reinisch W, Nahavandi H, Santella R, et al. Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study. Aliment Pharmacol Ther. 2001;15:1313-1322.
15. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med. 1995;332:292-297.
16. Cortot A, Colombel JF, Rutgeerts P, et al. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. Gut. 2001;48:186-190.